Bone Density Decline: Tenofovir has been related to a reduce in bone mineral density, growing the chance of bone complications or fractures. HIV-one contaminated subjects on dolutegravir monotherapy demonstrated rapid and dose-dependent reduction of antiviral exercise with declines of HIV-1 RNA copies per ml. The antiviral response was managed for https://hivhub.in/product/viropil-tablet/